Lv1
30 积分 2022-09-22 加入
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
1小时前
待确认
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
2小时前
已完结
First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions
5个月前
已关闭
NSCLC: Five trials to watch
5个月前
已完结
Discovery of Peripherally Restricted Indazole-Based Phosphodiesterase 4B Inhibitors Targeting the C-terminal Regulatory Helix for Treating Acute Lung Injury
7个月前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
9个月前
已完结
Precision Design of Fluorogenic Probes via Orthogonal Tuning of Binding and Photophysics for Isoform-Selective ALDH2 Imaging
11个月前
已完结
皖公网安备34019202002308
